![Natasha Hernday](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 95 708 $ in data 30/06/2026
Natasha A. Hernday is currently an Independent Director at Janux Therapeutics, Inc. since 2024.
Former positions include Director-Mergers, Acquisitions & Out-Partnering at Amgen, Inc. from 1994 to 2010; Independent Director at PDL BioPharma, Inc. from 2019 to 2022; Independent Director at Alpine Immune Sciences, Inc. from 2020 to 2024; Independent Director at XOMA Royalty Corp.
from 2020 to 2026; and Chief Business Officer at Seagen, Inc. from 2022 to 2023.
Education includes an MBA from Pepperdine University and an undergraduate degree from the University of California, Santa Barbara.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 11/06/2026 | 6.231 ( 0,01% ) | 95 708 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 19/07/2024 |
| Società | Posizione | Fine |
|---|---|---|
| XOMA ROYALTY CORPORATION | Direttore/Membro del Consiglio | 14/07/2026 |
| ALPINE IMMUNE SCIENCES, INC. | Direttore/Membro del Consiglio | 20/05/2024 |
| SEAGEN INC. | Corporate Officer/Principal | 01/01/2023 |
| PDL BIOPHARMA, INC. | Direttore/Membro del Consiglio | 01/12/2022 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2010 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Pepperdine University
 Pepperdine University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
Alpine Immune Sciences, Inc.
 Alpine Immune Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as an bio pharmaceutical company that develops immunotherapies for autoimmune and inflammatory diseases | Health Technology |
Janux Therapeutics, Inc.
 Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
